[Tuberculous otitis media: A case presentation and review of european literature].

Otitis media tuberculosa: Presentación de un caso y revisión de la literatura europea.
Mycobacterium tuberculosis antituberculous therapy chronic otitis media otitis media

Journal

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
ISSN: 1988-9518
Titre abrégé: Rev Esp Quimioter
Pays: Spain
ID NLM: 9108821

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 25 9 2023
pubmed: 2 6 2023
entrez: 2 6 2023
Statut: ppublish

Résumé

Tuberculous otitis media (TOM) is a rare affectation in our environment that represents a challenge in its diagnosis due to the non-specific symptoms that it usually presents. This paper presents our experience in the diagnosis of a case of TOM in a 66-year-old woman with hearing loss and chronic otorrhea of more than 6 months of evolution that did not respond to conventional treatments. In addition, a review of the cases published in the last 20 years (2000-2022) in countries of the European Union (EU) is carried out. The most common symptoms were otorrhea (n=43; 100%), hearing loss (n=37; 86.05%), eardrum perforation (n=19; 44.18%), facial paralysis (n=12, 27,91%) and ear pain (n=13; 30,23%). The most used sample for diagnosis was the biopsy obtained by mastoidectomy (n=34; 79.06%). All patients were given antituberculous therapy for a mean duration of 8.11 months (range, 6-12 months). The most frequent aftereffect was hearing loss (n=28; 65.12%). TOM should be included in the differential diagnosis of chronic suppurative otitis, since early diagnosis and treatment reduce the probability of suffering irreversible sequelae.

Identifiants

pubmed: 37265448
doi: 10.37201/req/011.2023
pmc: PMC10586746
pii:
doi:

Types de publication

Case Reports Review English Abstract Journal Article

Langues

spa

Sous-ensembles de citation

IM

Pagination

519-525

Informations de copyright

©The Author 2023. Published by Sociedad Española de Quimioterapia. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)(https://creativecommons.org/licenses/by-nc/4.0/).

Références

J Infect. 2010 Jul;61(1):96-9
pubmed: 20394770
Eur Arch Otorhinolaryngol. 2014 Jul;271(7):2083-9
pubmed: 24609650
Med Mal Infect. 2008 Nov;38(11):608-11
pubmed: 18954947
J Craniofac Surg. 2020 Sep;31(6):e552-e553
pubmed: 32371689
Am J Otolaryngol. 2022 Sep-Oct;43(5):103571
pubmed: 35963106
Int J Pediatr Otorhinolaryngol. 2002 Aug 1;65(1):59-63
pubmed: 12127224
BMJ Case Rep. 2020 Dec 9;13(12):
pubmed: 33298491
Case Rep Infect Dis. 2011;2011:932608
pubmed: 22570801
J Laryngol Otol. 2011 Jul;125(7):738-40
pubmed: 21693076
BMJ Case Rep. 2010 Dec 01;2010:
pubmed: 22798297
J Surg Case Rep. 2019 Apr 03;2019(4):rjz093
pubmed: 30967931
Pathol Res Pract. 2002;198(1):31-5
pubmed: 11866208
Eur Radiol. 2009 Jun;19(6):1560-3
pubmed: 19440720
Infect Dis (Lond). 2017 Mar;49(3):223-224
pubmed: 27389342
Auris Nasus Larynx. 2001 Aug;28(3):241-3
pubmed: 11489368
An Pediatr (Barc). 2006 Jan;64(1):104-6
pubmed: 16539928
Case Rep Med. 2011;2011:675807
pubmed: 21541186
Laryngoscope. 1953 Nov;63(11):1058-77
pubmed: 13110208
J Int Adv Otol. 2016 Aug;12(2):219-221
pubmed: 27716611
J Clin Microbiol. 2015 Jan;53(1):336-8
pubmed: 25339389
BMJ Case Rep. 2022 Aug 25;15(8):
pubmed: 36007975
Laryngorhinootologie. 2008 Jul;87(7):503-6
pubmed: 18688924
Arch Pediatr. 2006 Sep;13(9):1233-5
pubmed: 16829062
J Infect Public Health. 2021 Jan;14(1):139-142
pubmed: 33234409
Rev Esp Quimioter. 2018 Apr;31(2):182-183
pubmed: 29616516
Acta Otorhinolaryngol Ital. 2015 Apr;35(2):125-8
pubmed: 26019398
Otolaryngol Head Neck Surg. 2004 Jun;130(6):759-66
pubmed: 15195064
Scand J Infect Dis. 2000;32(4):436-8
pubmed: 10959661

Auteurs

M Aguilera-Franco (M)

María Aguilera Franco, Servicio de Microbiología y Parasitología Clínica. Hospital Universitario Virgen de las Nieves. Granada. Spaun. maguilfran@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH